Tenet Healthcare Corporation THC
At closeNov 5, 2026, 4:00 AM EST
Pre-market · Nov 5, 4:00 AM ET
- YTD
- +47.07%
- 1 year
- +40.69%
- Market cap
- 23.26B
- Revenue (ttm)
- 22.15B
- Profit margin
- 13.09%
- EPS (ttm)
- 34.29
- Shares out
- 79.59M
- P/E ratio
- 8.52
- Forward P/E
- 14.29
- YTD return
- +47.07%
- 1-year return
- +40.69%
- Volume
- 2.06M
- Avg volume
- 754.78K
- Open
- 280.00
- Previous close
- 266.69
- Day's range
- 279.59 – 294.11
- 52-week range
- 157.58 – 294.11
- Beta
- 1.20
- Analysts
- Buy
- Price target
- 304.14 (+4.1%)
- Earnings date
- Feb 10, 2027
2Y +125.38 (+75.14%)
Key statistics
- Enterprise value
- 35.94B
- PEG ratio
- 1.89
- Price / sales
- 1.05
- Price / book
- 4.27
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 6.50%
- Free cash flow
- 2.03B
- Total cash
- 2.67B
- Total debt
- 13.24B
- Return on equity
- 41.70%
- Short % of float
- 2.71%
- 50-day average
- 264.40
- 200-day average
- 220.89
Analyst view
Consensus: buy
- Target (low)
- 265.00
- Target (mean)
- 304.14
- Target (high)
- 342.00
- Strong buy5
- Buy14
- Hold4
- Sell0
- Strong sell0
Next earnings
Feb 10, 2027
Expected Feb 10, 2027. Consensus EPS estimate 5.35.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 10, 2027 | Dec 30, 2026 | 5.36 | — | — | — |
| Oct 29, 2026 | Sep 30, 2026 | 4.68 | 6.64 | +1.96 | +41.88% |
| Jul 22, 2026 | Jun 30, 2026 | 4.26 | 6.12 | +1.86 | +43.66% |
| Apr 30, 2026 | Mar 31, 2026 | 4.17 | 4.82 | +0.65 | +15.59% |
| Feb 11, 2026 | Dec 31, 2025 | 4.07 | 4.70 | +0.63 | +15.48% |
| Oct 28, 2025 | Sep 30, 2025 | 3.34 | 3.70 | +0.36 | +10.78% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 4, 2026 | Barclays | main | Overweight | Overweight |
| Nov 3, 2026 | Truist Securities | reit | Buy | Buy |
| Nov 3, 2026 | Keybanc | main | Overweight | Overweight |
| Nov 2, 2026 | Leerink Partners | main | Outperform | Outperform |
| Nov 2, 2026 | RBC Capital | main | Outperform | Outperform |
| Nov 2, 2026 | Wells Fargo | main | Overweight | Overweight |
About Tenet Healthcare Corporation
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; pediatric quaternary care services through heart, liver, and kidney transplants programs; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging technology, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services comprising orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. Further, the company operates acute care and specialty hospitals, off-campus emergency departments, imaging centers, urgent care centers, and micro-hospitals, as well as ambulatory surgery centers and surgical hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- United States
- Website
- tenethealth.com
News
Barclays Maintains Overweight on Tenet Healthcare, Raises Price Target to $297
Healthcare Stocks Bounce on Midterm Results. A Bull Market Case Is Developing.
Tenet Healthcare Corporation (THC) Is a Trending Stock: Facts to Know Before Betting on It Truist Securities Reiterates Buy on Tenet Healthcare, Raises Price Target to $305
Keybanc Maintains Overweight on Tenet Healthcare, Raises Price Target to $300
Leerink Partners Maintains Outperform on Tenet Healthcare, Raises Price Target to $342
RBC Capital Maintains Outperform on Tenet Healthcare, Raises Price Target to $304
Wells Fargo Maintains Overweight on Tenet Healthcare, Raises Price Target to $321
Tenet Healthcare Q3 Earnings Call Highlights
THC Q3 Earnings Call Highlights Higher Outlook and Margin Gains
Your note
Sign in to keep a note on THC — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ARBOUR PAOLA M | Chief Technology Officer | Sale | Jul 26, 2026 | 18,413 |
| BIERMAN JAMES L | Director | Sale | Jul 26, 2026 | 31,604 |
| FISHER RICHARD W. | Director | Conversion of Exercise of derivative security | May 21, 2026 | 9,632 |
| FITZGERALD MEGHAN | Director | Conversion of Exercise of derivative security | May 21, 2026 | 17,087 |
| HANEY CECIL D. | Director | Stock Gift | Aug 27, 2026 | 12,403 |
| MARK RICHARD J | Director | Sale | Sep 9, 2026 | 25,121 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 10.99% | 8,743,005 | 2.56B | Jun 29, 2026 |
| Price (T.Rowe) Associates Inc | 10.00% | 7,957,449 | 2.33B | Jun 29, 2026 |
| Boston Partners | 5.57% | 4,433,360 | 1.30B | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 5.33% | 4,238,108 | 1.24B | Jun 29, 2026 |
| FMR, LLC | 5.02% | 3,994,545 | 1.17B | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.89% | 3,894,189 | 1.14B | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.60% | 2,868,116 | 838.16M | Sep 29, 2026 |
| TR PRICE-Price (T.Rowe) U.S. Value Equity Trust | 3.57% | 2,840,356 | 830.05M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.44% | 2,734,962 | 799.25M | Jun 29, 2026 |
| T. Rowe Price Value Fund, Inc. | 2.63% | 2,092,106 | 611.38M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.48% | 1,975,296 | 577.25M | Jun 29, 2026 |
| John Hancock Funds III-Disciplined Value Mid Cap Fund | 1.86% | 1,483,123 | 433.42M | Aug 30, 2026 |
